Grants Reporting

Grants Reporting

The following table details all grants that Cancer Australia has funded since 1 January 2009.

Agency / Program Title / Program Component
(if applicable) / Recipient / Purpose / Value / Date of Effect / Grant Term (months) / Grant Funding Location / Postcode /
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Anti - Cancer Foundation of South Australia / Continuing Implementation of the National Cancer Data Strategy / $34,402.50 / 01/01/2011 / 3 / Eastwood SA / 5063
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Griffith University / 2010 PdCCRS: ProsCan for Life: A Multimodal Supportive Care Intervention for Men with Prostate Cancer / $329,006.70 / 24/01/2011 / 36 / Nathan QLD / 4111
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Cancer Institute NSW / Maintaining the eviQ Primary Health Care modules / $119,900.00 / 01/03/2011 / 16 / Australian Technology Park, NSW / 2015
Cancer Australia / Improved Cancer Control / Improved Cancer Control / The University of Western Australia / 2010 PdCCRS: Endocrine therapies for early breast cancer: targets the National Health Priority Area of Cancer Control, specifically focussing on breast cancer treatment in Australian women / $171,048.90 / 4/02/2011 / 39 / Crawley WA / 6009
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Cancer Council QLD / 2010 PdCCRS - A multi-level investigation of inequalities in clinical and psychosocial outcomes for women after breast cancer / $647,619.50 / 2/02/2011 / 39 / Fortitude Valley, QLD / 4006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2010 PdCCRS: Phase III randomised trial of post mastectomy chest wall irradiation in intermediate risk operable breast cancer / $561,000.00 / 9/02/2011 / 39 / Parkville VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2010 PdCCRS: Genetic and environmental factors in invasive cervical cancer: a twin study / $429,458.70 / 9/02/2011 / 27 / Parkville VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2010 PdCCRS: Fulfilling the vision of youth-friendly cancer care: How well are we meeting the psychosocial needs of AYA patients? / $164,776.70 / 9/02/2011 / 41 / Parkville VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Originally University of Melbourne now Ludwig Institute of Cancer Research / 2010 PdCCRS: Identifying therapeutic targets by profiling DNA repair in lung cancer CA-A1011/18 / $552,776.40 / 9/02/2011 / 46 / Heidelberg VIC / 3084
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2010 PdCCRS: Personalised breast cancer risk prediction in BRCA mutation carriers / $152,780.10 / 9/02/2011 / 39 / Parkville VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2010 PdCCRS: Identification of Men with a genetic predisposition to Prostate Cancer: targeted screening in BRCA1/2 mutation carriers and controls - The Impact study / $465,329.70 / 9/02/2011 / 39 / Parkville VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Queensland Institute of Medical Research / 2010 PdCCRS: microRNA miR-211 as a novel tumour suppressor for melanoma / $49,500.00 / 21/01/2011 / 16 / Herston QLD / 4006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Queensland Institute of Medical Research / 2010 PdCCRS: Development of a model to classify mismatch repair gene sequence variants of uncertain clinical significance / $660,000.00 / 21/01/2011 / 53 / Herston QLD / 4006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of New South Wales / 2010 PdCCRS: Identification of anti-apoptotic signalling pathways in malignant gliomas / $49,500.00 / 15/02/2011 / 15 / Sydney NSW / 2052
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of New South Wales / 2010 PdCCRS: Role of dietary compounds on PGC-1 alpha methylation in colorectal cancer / - / 15/02/2011 / 39 / Sydney NSW / 2052
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Queensland Institute of Medical Research / 2010 PdCCRS: Identifying markers of risk and outcome in ovarian and breast cancer via efficient of DNA methylation in peripheral blood / $191,213.00 / 8/02/2011 / 39 / Herston QLD / 4006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of New South Wales / 2010 PdCCRS: Targeting drug resistant genes in brain cancer: delivery of siRNA to improve cancer therapy / $49,500.00 / 15/02/2011 / 15 / Sydney NSW / 2052
Cancer Australia / Improved Cancer Control / Improved Cancer Control / The Australian National University / 2010 PdCCRS: Targeting of two Aspects of Metabolism (TOTAM) for cancer therapy / 546,165.40 / 14/02/2011 / 39 / Canberra ACT / 0200
Cancer Australia / Improved Cancer Control / Improved Cancer Control / The Australian Lung Foundation / Travel grants for lung cancer nurses to attend the International Lung Cancer Conference in Amsterdam / $22,800.00 / 29/03/2011 / 6 / Bowen Hills, QLD / 4006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Queensland / Auto fluorescence imaging for early detection and surgical margin delineation of oral cancers and pre-cancers / $558,131.20 / 21/02/2011 / 39 / St Lucia, QLD / 4072
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Adelaide / The role of CD123 in MDSA and AML / $316,276.40 / 24/02/2011 / 38 / North Terrace, SA / 5005
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: Whole Brain Radiotherapy following local treatment of intracranial metastases of melanoma - a randomised phase III trial / $650,111.00 / 01/03/2011 / 38 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: A randomised, placebo-controlled trial of concurrent cediranib [AZD2171] with platinum - based chemotherapy & maintenance cediranib in women with platinum sensitive relapsed ovarian cancer: ICON 6 / $270,597.80 / 01/03/2011 / 27 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: Tumour protein D52 over-expression and DNA repair in cancer / $48,132.40 / 01/03/2011 / 15 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: START Phase III Study of Active Surveillance Therapy Against Radical Treatment in Patients Diagnosed with Favourable Risk Prostate Cancer / $329,320.20 / 01/03/2011 / 38 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Curtin University of Technology / 2010 PdCCRS: Meeting the education and support needs of women with breast cancer who are referred for radiotherapy: A multiple - baseline study / $220,993.30 / 01/03/2011 / 51 / Perth, WA / 6845
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Adelaide / 2010 PdCCRS: A novel approach to predict metastatic potential of prostate cancer at diagnosis / $650,905.20 / 01/03/2011 / 38 / Adelaide, SA / 5005
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: The impact of aberrant progesterone signalling on lineage specification during early malignant transformation / $48,129.40 / 01/03/2011 / 15 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: Alternative lengthening of Telomeres (ALT) in lung cancer: analysis of effects on patient outcomes and development of a blood test / $48,981.90 / 01/03/2011 / 15 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2010 PdCCRS: NITRO - A randomised, phase 3 trial of adding nitro-glycerine to first line chemotherapy for advanced non - small cell lung cancer / $656,421.70 / 01/03/2011 / 38 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Queensland Health / Cancer care coordination for Indigenous people residing in Far North Queensland / $438,743.80 / 25/05/2011 / 18 / Brisbane, QLD / 4000
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Monash University / 2010 PdCCRS: Determining the causes of observed variation in survival after diagnosis of prostate cancer / $627,607.20 / 30/05/2011 / 36 / Clayton, VIC / 3800
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Clinical Oncology Society of Australia / Building Cancer Support Networks Initiative - Better Cancer Support through Consumers (BCSN) / $297,0000.00 / 2/6/2011 / 12 / Sydney. NSW / 2010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / Sequencing the ovarian cancer genome: molecular determinants of tumour growth & treatment failure / $660,000.00 / 30/06/2011 / 35 / Parkville, VIC / 3010
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Queensland University of Technology / Skin cancer prevention & early detection for Generation Y / $343,776.40 / 30/06/2011 / 24 / Brisbane, QLD / 4001
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Austin Health / Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period. / $35,255.54 / 30/06/2011 / 6 / Heidelberg VIC / 3084
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Prince Charles Hospital / Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period. / $18,820.20 / 30/06/2011 / 6 / Chermside, QLD / 4032
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Royal Hobart Hospital (Department of Health and Human Services) / Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period. / $12,425.24 / 30/06/2011 / 6 / Hobart, TAS / 7000
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Nepean Hospital / Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period. / $27,056.13 / 30/06/2011 / 6 / Penrith, NSW / 2751
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Peter MacCallum Cancer Centre / For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer / $36,960.00 / 30/06/2011 / 5 / A'Beckett Street, VIC / 8006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Women's and Children's Hospital / For the provision of Pilot Testing of a Data Set Specifications (DSS) for Adolescents and Young Adults with Cancer / $16,648.50 / 24/06/2011 / 5 / North Adelaide, SA / 5006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / South Eastern Sydney Local Health District / Pilot project will obtain information on feasibility of data collection of the DSS items and the rate of data-item completion during the pilot project period. / $16,376.80 / 27/07/2011 / 4 / Randwick, NSW / 2031
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Breast Cancer Network Australia / For the provision of projects that aim to strengthen support for women with breast cancer / $1,366,200.00 / 04/11/2011 / 31 / Camberwell, VIC / 3124
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2011 PdCCRS – The role of adjuvant chemotherapy in high-risk endometrial cancer / $330,965.80 / 09/01/2012 / 36 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2011 PdCCRS – Phase III trial of Concurrent and Adjuvant Temozolomide chemotherapy in non-1p/19q non deleted anaplastic glioma - The CATNON Intergroup Trial. / $217,896.25 / 09/01/2012 / 36 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Ludwig Institute for Cancer Research / 2011 PdCCRS - Discovery of colorectal cancer subtype associated tumour suppressor genes using next-generation sequencing and high throughput functional genomics / $482,476.50 / 02/02/2012 / 36 / Heidelberg, VIC / 3084
Cancer Australia / Improved Cancer Control / Improved Cancer Control / Edith Cowan University / 2011 PdCCRS - Can exercise ameliorate treatment toxicity during the initial phase of testosterone suppression in prostate patients? Is this more effective than delayed rehabilitation and what is the time course and persistence of benefits? / $163,634.45 / 02/02/2012 / 36 / Joondalup, WA / 6027
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2011 PdCCRS - Evaluation of web-based tool for estimating and explaining prognosis in advanced cancer / $139,933.75 / 09/01/2012 / 36 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Sydney / 2011 PdCCRS - Evaluation of a psychological and educational intervention for fear of cancer recurrence; A cluster randomised controlled trial / $182,124.07 / 09/01/2012 / 54 / Sydney, NSW / 2006
Cancer Australia / Improved Cancer Control / Improved Cancer Control / University of Melbourne / 2011 PdCCRS - Targeting dormancy in metastatic breast cancer / $148,179.90 / 23/02/2012 / 36 / Melbourne, VIC / 3010